Songwei Tan

5.3k total citations · 3 hit papers
72 papers, 4.5k citations indexed

About

Songwei Tan is a scholar working on Biomaterials, Biomedical Engineering and Molecular Biology. According to data from OpenAlex, Songwei Tan has authored 72 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Biomaterials, 30 papers in Biomedical Engineering and 24 papers in Molecular Biology. Recurrent topics in Songwei Tan's work include Nanoparticle-Based Drug Delivery (27 papers), Nanoplatforms for cancer theranostics (23 papers) and RNA Interference and Gene Delivery (20 papers). Songwei Tan is often cited by papers focused on Nanoparticle-Based Drug Delivery (27 papers), Nanoplatforms for cancer theranostics (23 papers) and RNA Interference and Gene Delivery (20 papers). Songwei Tan collaborates with scholars based in China, United States and Iran. Songwei Tan's co-authors include Zhiping Zhang, Zhiping Zhang, Yuanyuan Guo, Tingting Wu, Si‐Shen Feng, Yuling Bao, Dan Zhang, Xiangting Zhuang, Jun Luo and Qingle Song and has published in prestigious journals such as Advanced Materials, SHILAP Revista de lepidopterología and Nano Letters.

In The Last Decade

Songwei Tan

70 papers receiving 4.4k citations

Hit Papers

Vitamin E TPGS as a molecular biomaterial for drug delivery 2012 2026 2016 2021 2012 2013 2015 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Songwei Tan China 29 1.9k 1.8k 1.7k 718 623 72 4.5k
Wenbing Dai China 46 2.6k 1.4× 2.2k 1.2× 2.3k 1.4× 609 0.8× 801 1.3× 133 5.5k
Bing He China 43 2.0k 1.1× 1.8k 1.0× 2.2k 1.3× 456 0.6× 719 1.2× 141 5.3k
Rebecca M. Haley United States 12 2.0k 1.0× 2.1k 1.2× 2.3k 1.4× 588 0.8× 425 0.7× 21 5.8k
Lesheng Teng China 43 1.7k 0.9× 1.5k 0.8× 2.6k 1.6× 417 0.6× 417 0.7× 166 5.4k
Shuangjiang Yu China 33 1.2k 0.6× 1.7k 0.9× 809 0.5× 525 0.7× 404 0.6× 77 3.5k
Tao Sun China 38 1.8k 0.9× 2.0k 1.1× 2.0k 1.2× 769 1.1× 582 0.9× 130 5.0k
Ying Zhao China 32 2.3k 1.2× 2.5k 1.3× 1.9k 1.1× 593 0.8× 757 1.2× 75 5.3k
Minjie Sun China 40 1.5k 0.8× 2.2k 1.2× 1.7k 1.0× 531 0.7× 448 0.7× 129 4.5k
Hangxiang Wang China 43 1.7k 0.9× 2.0k 1.1× 1.8k 1.1× 411 0.6× 703 1.1× 122 5.0k
Laiqiang Huang China 37 1.9k 1.0× 1.4k 0.8× 2.0k 1.2× 251 0.3× 624 1.0× 101 5.0k

Countries citing papers authored by Songwei Tan

Since Specialization
Citations

This map shows the geographic impact of Songwei Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Songwei Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Songwei Tan more than expected).

Fields of papers citing papers by Songwei Tan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Songwei Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Songwei Tan. The network helps show where Songwei Tan may publish in the future.

Co-authorship network of co-authors of Songwei Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Songwei Tan. A scholar is included among the top collaborators of Songwei Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Songwei Tan. Songwei Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Huaxi, Danya Zhang, Yu Zhang, et al.. (2025). TMTP1-modified nanocarrier boosts cervical cancer immunotherapy by eliciting pyroptosis. Theranostics. 15(11). 5420–5439. 1 indexed citations
2.
3.
Li, Fan, et al.. (2025). Nanomedicine Approaches for Intervertebral Disc Regeneration: From Bench to Bedside. Pharmaceutics. 17(3). 313–313. 4 indexed citations
5.
Tu, Yaqin, Yanan Zhu, Qianru Li, et al.. (2025). Metabolic reprogramming by chemo-gene co-delivery nanoparticles for chemo-immunotherapy in head and neck squamous cell carcinoma. Acta Biomaterialia. 199. 361–373. 6 indexed citations
6.
Gao, Xueqin, et al.. (2024). Chitosan-Functionalized Poly(β-Amino Ester) Hybrid System for Gene Delivery in Vaginal Mucosal Epithelial Cells. Pharmaceutics. 16(1). 154–154. 16 indexed citations
7.
Liu, Jun, Songwei Tan, Wei Wang, et al.. (2023). The Inhibition Effect and Mechanism of Nano Magnesium Peroxide Against Spoilage Fungi Emerging in Hami Melon. Food and Bioprocess Technology. 16(9). 2027–2038. 4 indexed citations
8.
Wang, Xueqian, Guiying Jiang, Danya Zhang, et al.. (2023). A TMVP1-modified near-infrared nanoprobe: molecular imaging for tumor metastasis in sentinel lymph node and targeted enhanced photothermal therapy. Journal of Nanobiotechnology. 21(1). 130–130. 19 indexed citations
9.
Tu, Yaqin, Guorun Fan, Jiahui Ding, et al.. (2022). Enhanced photodynamic therapy/photothermo therapy for nasopharyngeal carcinoma via a tumour microenvironment-responsive self-oxygenated drug delivery system. Asian Journal of Pharmaceutical Sciences. 17(2). 253–267. 32 indexed citations
10.
Tang, Qing, Wei Zhang, Chong Zhang, et al.. (2020). Oxymatrine loaded nitric oxide-releasing liposomes for the treatment of ulcerative colitis. International Journal of Pharmaceutics. 586. 119617–119617. 33 indexed citations
11.
Yang, Guan, et al.. (2020). Recent Advances of D-α-tocopherol Polyethylene Glycol 1000 Succinate Based Stimuli-responsive Nanomedicine for Cancer Treatment. Current Medical Science. 40(2). 218–231. 38 indexed citations
12.
Wang, Huan, Wei Zhang, Chenming Zou, et al.. (2020). <p>Oxymatrine Liposomes for Intervertebral Disc Treatment: Formulation, in vitro and vivo Assessments</p>. Drug Design Development and Therapy. Volume 14. 921–931. 23 indexed citations
13.
Wang, Qiong, Chenming Zou, Xueqin Gao, et al.. (2019). Doxorubicin and adjudin co-loaded pH-sensitive nanoparticles for the treatment of drug-resistant cancer. Acta Biomaterialia. 94. 469–481. 47 indexed citations
15.
Kong, Miao, Qi Qiao, Tingting Wu, et al.. (2017). Biodegradable Hollow Mesoporous Silica Nanoparticles for Regulating Tumor Microenvironment and Enhancing Antitumor Efficiency. Theranostics. 7(13). 3276–3292. 160 indexed citations
16.
Chu, Qian, Xun Yuan, Wenxiang Ji, et al.. (2016). A novel paclitaxel-loaded poly(D,L-lactide-co-glycolide)-Tween 80 copolymer nanoparticle overcoming multidrug resistance for lung cancer treatment. International Journal of Nanomedicine. 11. 2119–2119. 26 indexed citations
17.
Bao, Yuling, Mingxing Yin, Xiaomeng Hu, et al.. (2016). A safe, simple and efficient doxorubicin prodrug hybrid micelle for overcoming tumor multidrug resistance and targeting delivery. Journal of Controlled Release. 235. 182–194. 129 indexed citations
18.
Tan, Songwei, Tingting Wu, Dan Zhang, & Zhiping Zhang. (2015). Cell or Cell Membrane-Based Drug Delivery Systems. Theranostics. 5(8). 863–881. 410 indexed citations breakdown →
19.
Chu, Qian, et al.. (2015). D-&alpha;-tocopherol polyethylene glycol succinate-based derivative nanoparticles as a novel carrier for paclitaxel delivery. International Journal of Nanomedicine. 10. 5219–5219. 26 indexed citations
20.
Tan, Songwei, Xu Li, Yajun Guo, & Zhiping Zhang. (2012). Lipid-enveloped hybrid nanoparticles for drug delivery. Nanoscale. 5(3). 860–860. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026